Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Fadi Braiteh, Michael C. Cerio


MolecularHealth announced that Fadi Braiteh has joined its advisory board. Braiteh is an oncologist with Comprehensive Cancer Centers of Nevada, specializing in gastro-intestinal, digestive system, and breast cancers.

He has received a number of awards for his work in cancer, including the 2009 Susan G. Komen Scholar-In-Training Award, the 2007 Jesse Jones Fellowship in Cancer Education Award, and the 2005 and 2006 ASCO Foundation Merit Awards.

Signal Genetics announced it has appointed Michael C. Cerio its Senior Vice President of commercial strategy and business development.

Cerio has worked in business development in the diagnostics and biotech industry for 15 years, most recently as an independent consultant with the life science venture capital firm MPM Capital. Prior to that, he served as Consulting CEO for Modulation Therapies and President and CEO of Oncolome Diagnostics. Cerio also worked at Genzyme Corporation, BG Medicine and Genaissance Pharmaceuticals.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.